 | This article relies largely or entirely on a
single source. (October 2020) |
Pyrrolobenzodiazepines, (PBD) are a class of compound that may have antibiotic or anti-tumor properties. [1]
Some dimeric pyrrolobenzodiazepines are used as the cytotoxic drug payloads in antibody-drug conjugates, for example in loncastuximab tesirine.
History
Anthramycin, the first PBD monomer, was first synthesized in the 1960s. [2]
References
- ^ Hartley JA (June 2011). "The development of pyrrolobenzodiazepines as antitumour agents". Expert Opinion on Investigational Drugs. 20 (6): 733–44. doi: 10.1517/13543784.2011.573477. PMID 21457108. S2CID 26275418.
- ^ From Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs) Angew Chem Int Ed Engl. 2017 Jan 9; 56(2): 462–488. Published online 2016 Nov 15. doi: 10.1002/anie.201510610
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
 | This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it. |